Nicholson-Weller A - Search Results

1

C3 glomerulonephritis secondary to mutations in factors H and I: rapid recurrence in deceased donor kidney transplant effectively treated with eculizumab.

Garg N, Zhang Y, Nicholson-Weller A, Khankin EV, Borsa NG, Meyer NC, McDermott S, Stillman IE, Rennke HG, Smith RJ, Pavlakis M. Garg N, et al. Among authors: nicholson weller a. Nephrol Dial Transplant. 2018 Dec 1;33(12):2260-2265. doi: 10.1093/ndt/gfx369. Nephrol Dial Transplant. 2018. PMID: 29370420 Free PMC article.

2

Increased susceptibility to endotoxin shock in complement C3- and C4-deficient mice is corrected by C1 inhibitor replacement.

Fischer MB, Prodeus AP, Nicholson-Weller A, Ma M, Murrow J, Reid RR, Warren HB, Lage AL, Moore FD Jr, Rosen FS, Carroll MC. Fischer MB, et al. J Immunol. 1997 Jul 15;159(2):976-82. J Immunol. 1997. PMID: 9218619

3

Serum amyloid P component forms a stable complex with human C5b6.

Barbashov SF, Wang C, Nicholson-Weller A. Barbashov SF, et al. J Immunol. 1997 Apr 15;158(8):3830-5. J Immunol. 1997. PMID: 9103450

4

Human complement receptor type 1/CD35 is an Epstein-Barr Virus receptor.

Ogembo JG, Kannan L, Ghiran I, Nicholson-Weller A, Finberg RW, Tsokos GC, Fingeroth JD. Ogembo JG, et al. Among authors: nicholson weller a. Cell Rep. 2013 Feb 21;3(2):371-85. doi: 10.1016/j.celrep.2013.01.023. Epub 2013 Feb 14. Cell Rep. 2013. PMID: 23416052 Free PMC article.

5

Terminal complement proteins C5b-9 release basic fibroblast growth factor and platelet-derived growth factor from endothelial cells.

Benzaquen LR, Nicholson-Weller A, Halperin JA. Benzaquen LR, et al. J Exp Med. 1994 Mar 1;179(3):985-92. doi: 10.1084/jem.179.3.985. J Exp Med. 1994. PMID: 8113689 Free PMC article.

6

Critical role of the complement system in group B streptococcus-induced tumor necrosis factor alpha release.

Levy O, Jean-Jacques RM, Cywes C, Sisson RB, Zarember KA, Godowski PJ, Christianson JL, Guttormsen HK, Carroll MC, Nicholson-Weller A, Wessels MR. Levy O, et al. Infect Immun. 2003 Nov;71(11):6344-53. doi: 10.1128/IAI.71.11.6344-6353.2003. Infect Immun. 2003. PMID: 14573654 Free PMC article.

7

Signaling by hemolytically inactive C5b67, an agonist of polymorphonuclear leukocytes.

Wang C, Gerard NP, Nicholson-Weller A. Wang C, et al. J Immunol. 1996 Jan 15;156(2):786-92. J Immunol. 1996. PMID: 8543834

8

In vitro and in vivo responses of murine granulocytes to human complement-derived, haemolytically inactive C5b67 (iC5b67).

Wang C, Bozza PT, Barbashov SF, Sauty A, Nicholson-Weller A. Wang C, et al. Clin Exp Immunol. 1999 Aug;117(2):261-8. doi: 10.1046/j.1365-2249.1999.00962.x. Clin Exp Immunol. 1999. PMID: 10444256 Free PMC article.

9

C1q and C4b bind simultaneously to CR1 and additively support erythrocyte adhesion.

Tas SW, Klickstein LB, Barbashov SF, Nicholson-Weller A. Tas SW, et al. J Immunol. 1999 Nov 1;163(9):5056-63. J Immunol. 1999. PMID: 10528211

10

Hemolytically inactive C5b67 complex: an agonist of polymorphonuclear leukocytes.

Wang C, Barbashov S, Jack RM, Barrett T, Weller PF, Nicholson-Weller A. Wang C, et al. Blood. 1995 May 1;85(9):2570-8. Blood. 1995. PMID: 7727785 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

80 results

Search Page

Filters